Invention Application
- Patent Title: INHIBITORS OF NGAL PROTEIN
-
Application No.: US17434535Application Date: 2020-03-06
-
Publication No.: US20220054493A1Publication Date: 2022-02-24
- Inventor: Frédéric JAISSER , Ernesto MARTINEZ-MARTINEZ , Paul MULDER , Antoine OUVRARD-PASCAUD , Philippe BERNARD , Quoc Tuan DO
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITE DE ROUEN-NORMANDIE , GREENPHARMA , UNIVERSITE DE PARIS , SORBONNE UNIVERSITÉ
- Applicant Address: FR Paris; FR Mont-Saint-Aignan; FR Orleans; FR Paris; FR Paris
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE),UNIVERSITE DE ROUEN-NORMANDIE,GREENPHARMA,UNIVERSITE DE PARIS,SORBONNE UNIVERSITÉ
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE),UNIVERSITE DE ROUEN-NORMANDIE,GREENPHARMA,UNIVERSITE DE PARIS,SORBONNE UNIVERSITÉ
- Current Assignee Address: FR Paris; FR Mont-Saint-Aignan; FR Orleans; FR Paris; FR Paris
- Priority: EP19305259.4 20190306,EP19305665.2 20190527
- International Application: PCT/EP2020/056077 WO 20200306
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/4245 ; A61K31/415
Abstract:
This invention relates to compounds that are inhibitors of NGAL activity, and applications thereof.
Information query
IPC分类:
